Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients.
Rev Diabet Stud
; 8(2): 254-8, 2011.
Article
in En
| MEDLINE
| ID: mdl-22189548
ABSTRACT
OBJECTIVES:
It is generally accepted that in adult type 1 diabetes patients (T1D) continuous subcutaneous insulin infusion (CSII) via a personal pump is more effective than the multiple daily injections (MDI) model. However, it is not clear whether all age groups of adult T1D patients may equally benefit from CSII therapy. We aimed to compare the glycemic control and use of selected pump tools in T1D subjects using CSII over the age of 50 (50+ T1D) with patients younger than 50 years of age.METHODS:
The last available insulin pump/blood glucose meter downloads and last available HbA1c levels of 124 adult T1D subjects using CSII were reviewed. We divided our cohort into two subgroups 50+ T1D patients (n = 13) and younger patients (n = 111).RESULTS:
There were no differences in glycemic control achieved with CSII treatment in 50+ T1D patients vs. younger subjects. HbA1c levels were 7.01 ± 0.67% and 7.34 ± 1.24% (p = 0.46), and the mean glycemia based on glucometer downloads was 141.8 ± 17.7 mg/dl and 150.8 ± 35.7 mg/dl (p = 0.69), respectively. Also, there were no differences with respect to the use of important personal pump options and tools.CONCLUSION:
In conclusion, insulin pump therapy appears to be effective and safe in T1D patients regardless of age.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Insulin Infusion Systems
/
Infusion Pumps, Implantable
/
Diabetes Mellitus, Type 1
/
Hypoglycemic Agents
/
Insulin
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Rev Diabet Stud
Journal subject:
ENDOCRINOLOGIA
Year:
2011
Document type:
Article
Affiliation country:
Poland